Spironolactone; the ultimate blocker of RAAS cascade in hypertensive patients with special reference to its cardiovascular benefits: Revisiting the forgotten ways. Bangladesh Journal of Medical Science, [S. l.], v. 11, n. 2, p. 80–86, 2012. DOI: 10.3329/bjms.v11i2.8664. Disponível em: https://www.banglajol.info/index.php/BJMS/article/view/8664. Acesso em: 3 jul. 2026.